NCT00328965View on ClinicalTrials.gov

Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea

PHASE4CompletedINTERVENTIONAL

Timeline

Start Date

November 30, 2004

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions

Diabetes Mellitus, Type 2Essential Hypertension

Interventions

DRUG

Lacidipine

Lacidipine 2, 4, 6mg

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY